Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: Thomson Reuters Stock Report
Provider: S&P Capital IQ Quantitative Report
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BioDelivery Sciences International Inc Announces Regulatory Approval of ONSOLIS in Taiwan

Monday, 29 Jul 2013 07:10am EDT 

BioDelivery Sciences International, Inc. announced that the regulatory approval of ONSOLIS in Taiwan for the management of cancer pain in opioid tolerant, adult patients with cancer. In Taiwan, BDSI has licensed the commercialization rights to TTY Biopharm, where the product will be marketed under the brand name PAINKYL.